IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.66B | 4.55B | 4.45B | 4.30B | 4.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.66B | 4.55B | 4.45B | 4.30B | 4.17B |
| Cost of Revenue | 1.74B | 1.71B | 1.69B | 1.64B | 1.60B |
| Gross Profit | 2.92B | 2.84B | 2.76B | 2.66B | 2.57B |
| SG&A Expenses | 1.14B | 1.11B | 1.09B | 1.05B | 1.03B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.15B | 3.09B | 3.03B | 2.94B | 2.87B |
| Operating Income | 1.52B | 1.47B | 1.42B | 1.36B | 1.30B |
| Income Before Tax | 1.48B | 1.42B | 1.37B | 1.32B | 1.27B |
| Income Tax Expenses | 296.78M | 284.76M | 274.31M | 264.73M | 246.17M |
| Earnings from Continuing Operations | 1.18K | 1.14K | 1.10K | 1.06K | 1.03K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.18B | 1.14B | 1.10B | 1.06B | 1.03B |
| EBIT | 1.52B | 1.47B | 1.42B | 1.36B | 1.30B |
| EBITDA | 1.67B | 1.62B | 1.56B | 1.51B | 1.44B |
| EPS Basic | 14.91 | 14.32 | 13.69 | 13.18 | 12.71 |
| Normalized Basic EPS | 11.69 | 11.24 | 10.77 | 10.29 | 9.78 |
| EPS Diluted | 14.84 | 14.23 | 13.59 | 13.08 | 12.61 |
| Normalized Diluted EPS | 11.63 | 11.17 | 10.69 | 10.22 | 9.71 |
| Average Basic Shares Outstanding | 317.33M | 318.60M | 320.06M | 321.73M | 323.67M |
| Average Diluted Shares Outstanding | 319.00M | 320.63M | 322.31M | 324.07M | 326.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |